BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.

BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT)
Listen to this Section


$8.98
+0.5590 ( +6.64% ) 88.5K

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Market Data


Open $8.98
Previous Close $8.42
Volume 88.5K
Market Cap $674.50M
Day Range $8.21 - $9.04
52 Week Range $7.00 - $14.87
Shares Outstanding 80.11M
Change % +6.64%
Net Change ▲ 0.5590
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2025
CountryUnited States
UnderwriterLeerink Partners, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 12, 2025
10-q Quarterly Reports 82 Nov 12, 2025

Latest News